March 28, 2017
Milner Therapetucis Institute, Elysium Health partner up in developing preventive medicines
The Milner Therapeutics Institute is partnering up with Elysium Health to the Milner Therapeutics Consortium.
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
March 28, 2017
Mylan underpayment on EpiPen could exceed proposed settlement -study
The amount that drugmaker Mylan NV avoided paying the U.S. government in Medicaid rebates for its EpiPen emergency allergy treatment since 2007 likely exceeds a proposed $465 million settlement the company announced in October, according to a study by private drug pricing experts published on Monday.
March 28, 2017
FDA OK’s Tesaro’s ovarian cancer drug
The U.S. Food and Drug Administration has approved Tesaro’s Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.
March 27, 2017
Novo Nordisk’s new fast-acting mealtime insulin to sell in Canada
Novo Nordisk’s new, fast-acting mealtime insulin for the treatment of diabetes in adults, Fiasp has been launched in Canada, following the recent marketing authorisation from Health Canada on 6 January 2017.
March 24, 2017
Digital Pharmacist acquires a mobile app for managing prescriptions
Digital Pharmacist Inc., a digital health company, has acquired PocketRx, a mobile app that allows patients to manage their prescriptions.
March 24, 2017
FDA approves EMD Serono’s rare skin cancer drug
EMD Serono, U.S. company focused on specialty care has received U.S. Food and Drug Administration (FDA) approval for its rare skin cancer drug.
March 23, 2017
Latino population in USA have higher rates of cardio-metabolic diseases
Latino population in the United States of America have higher rates of cardio-metabolic diseases than in rest of the population, said David Kerr, director of Innovation and Research for the William Sansum Diabetes center.
March 23, 2017
Crunch week looms for Sanofi, Roche and GSK at U.S. drugs agency
Three of Europe’s top drugmakers face critical verdicts from U.S. regulators next week, with Sanofi <SASY.PA> and Roche <ROG.S> likely to win approvals for two new products, while GlaxoSmithKline <GSK.L> braces for a potential generic rival.
March 22, 2017
FDA OK’s Parkinson’s disease drug
The U.S. Food and Drug Administration has approved Newron Pharmaceuticals’s Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa.
March 21, 2017
Steep Hill Labs and iCAN:Israel-Cannabis join in cannabis business
Steep Hill Labs, a cannabis science and technology company has entered a joint venture with iCAN:Israel-Cannabis to leverage Steep Hill’s science, IP, methodology, global collaboration and brand.